The US Food and Drug Administration (FDA) has approved the first RSV vaccine. The product is registered for the prevention of RSV-induced lower respiratory tract disease in people 60 years of age and older.
- The elderly, especially those with conditions such as heart or lung disease or a weakened immune system, are particularly vulnerable to a severe form of RSV disease. The approval of the first RSV vaccine is an important step for public health. This vaccine prevents a disease that can be fatal," said Dr. Peter Marks director of the Center for Biologics Evaluation and Research at the FDA.
RSV is a highly contagious virus that causes lung and respiratory infections in people of all ages. The season of ill...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
